<html>
<head>PUBMED IDs for BBS11</head>
<body bgcolor='#C5F0F2'><h1>BBS11</h1><a href='https://pubmed.ncbi.nlm.nih.gov/16606853/'>Homozygosity mapping with SNP arrays identifies TRIM32, an E3 ubiquitin ligase, as a Bardet-Biedl syndrome gene (BBS11).</a> April 12  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17504209/'>The zebrafish model: use in studying cellular mechanisms for a spectrum of clinical disease entities.</a> May 17  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17994549/'>Mutations that impair interaction properties of TRIM32 associated with limb-girdle muscular dystrophy 2H.</a> November 13  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19303295/'>Use of SNP array analysis to identify a novel TRIM32 mutation in limb-girdle muscular dystrophy type 2H.</a> July 29  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19349376/'>TRIM32 is an E3 ubiquitin ligase for dysbindin.</a> August 14  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20177705/'>Identification of 28 novel mutations in the Bardet-Biedl syndrome genes: the burden of private mutations in an extensively heterogeneous disease.</a> April 29  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20177704/'>Alterations in p53, BRCA1, ATM, PIK3CA, and HER2 genes and their effect in modifying clinicopathological characteristics and overall survival of Bulgarian patients with breast cancer.</a> October 28  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21496629/'>Limb-girdle muscular dystrophy 2H and the role of TRIM32.</a> July 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/24500717/'>Interaction with the Bardet-Biedl gene product TRIM32/BBS11 modifies the half-life and localization of Glis2/NPHP7.</a> May 28  2014<br></body></html>
